Alterations in gastrointestinal microflora during antimicrobial therapy for necrotizing enterocolitis

Area of Science:

• Neonatal Medicine
• Microbiology
• Gastroenterology

Background:

• Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease in infants.
• Gram-negative bacteria, particularly Enterobacteriaceae, are implicated in NEC pathogenesis.
• Understanding microflora changes during NEC treatment is crucial.

Purpose of the Study:

• To investigate the impact of combined topical and parenteral antimicrobial therapy on gastrointestinal microflora in infants with NEC.
• To assess the reduction of specific bacterial populations during NEC treatment.

Main Methods:

• Analysis of gastric and fecal cultures from 22 infants undergoing antimicrobial therapy for NEC.
• Comparison of microbial profiles before and during treatment.

Main Results:

• Significant decrease in Gram-negative aerobic organisms, including Enterobacteriaceae, during antimicrobial therapy.
• The study demonstrated a reduction in implicated bacterial numbers with the applied therapy.

Conclusions:

• Combined antimicrobial therapy effectively reduces specific Gram-negative bacteria in the gastrointestinal tract of infants with NEC.
• This therapeutic strategy may help mitigate bacterial factors contributing to NEC development.